ACCESSO TECHNOLOGY GROUP PLC (ACSO) — Investment Research Note

Executive summary

Accesso is a vertical SaaS provider of ticketing, virtual queuing, distribution and guest-management software for theme parks, ski resorts, museums and live-entertainment venues (1,100+ venues, 31 countries). The trajectory across 2021–2025 has been a recovery from COVID followed by a frustrating plateau — revenue stalled at $155m in 2025 and 2026 is guided lower ($146m, $20m Cash EBITDA) as one major virtual-queuing customer churned and discretionary attendance softened. The single most important valuation point: the shares trade at ~5x EV/Cash EBITDA and ~7-8x adjusted EPS while the Group has £15m+ net cash, has just returned ~$36m via buyback + tender at £3.00, and the new Dexibit acquisition reframes the AI-receiver story — but 2026 is the third consecutive year of essentially flat sales.

Fair value estimate

• Fair value range: 280p – 380p per share (mid ~330p)
• Implied market cap range: £93m – £127m (mid ~£110m)
• Methodology: Blended EV/Cash-EBITDA multiple (primary) and forward P/E cross-check.
  • 2026E Cash EBITDA guidance: $20m (~£15m at 1.32). Net cash $30m + tender (£14.5m) outflow + Dexibit ($7.1m cash) → adj. net cash today ~£10-15m.
  • 7x–9x EV / Cash EBITDA on 2026E → EV $140–180m (£106–136m) → equity £116–146m. Per share at ~33.3m post-tender shares: 350-440p (upper range).
  • 7-9x forward adjusted EPS (~34p) → 240–305p (lower range).
  • Cross-check: a normalised mid-cycle EBITDA of ~$25m at 8x → ~£150m equity / ~450p; downside (3-year decline to $17m EBITDA at 6x) → ~£90m / 270p.
• Vs latest market cap £88m → upside ~25% to mid (330p), with range -2% to +44%.
• View: undervalued, but the bull case requires 2026 to mark the trough.

Sector context

• Sector: Technology / Application Software (vertical SaaS for leisure & entertainment).
• The Group's quality profile is in line with small-cap vertical SaaS — 78% gross margin and 84% recurring revenue are good, but 1-2% top-line growth and 14-15% Cash EBITDA margin sit below better-performing peers (typically 20%+).
• Listed peers: Globant (ticketing-adjacent IT services), Eventbrite (EB), and on the LSE/AIM the most comparable peers are arguably Cerillion (CER), GlobalData (DATA) and other small-cap vertical SaaS names. No direct UK pure-play comp; private ticketing peers include Gateway Ticketing and CenterEdge.

Investment thesis

1. Capital-return-driven cheap vertical SaaS with net cash and patient owners — Group returned $35.9m (≈40% of current market cap) via two 2025 buybacks plus the £14.5m post-period tender at £3.00, signalling Board belief that the shares are "meaningfully undervalued" 2026-03-30 Final Results & 2026-01-29 Tender Offer. With $30m+ year-end net cash and an undrawn $28.7m of a $40m facility, ongoing returns are funded from internal cash flow.
2. Mission-critical, transaction-based system-of-record with patent-protected virtual queuing — 84.6% repeatable revenue mix, 25-year patent portfolio (recently defended in 2025), 43 new venue wins in 2025 vs 30 prior year, and accelerating Freedom adoption (63 venues signed vs 11 prior year) point to durable wins under a refreshed commercial team 2026-03-30 Final Results. The 5-7 year customer agreements with operators like Village Roadshow, Six Flags-Saudi/Qiddiya, and One VGS underwrite long-tail revenue.
3. Cheap optionality on the Dexibit AI thesis — March 2026 acquisition of Dexibit (NZ$20.9m / ~US$12.1m max) brings a purpose-built attractions AI/analytics platform with 100+ system integrations and ~$1.4m ARR. The new "accesso Intelligence" layer sits above all products and operator third-party systems, with potential to be a meaningful incremental revenue line over 3-5 years given accesso's 1,100-venue installed base and transaction-based pricing 2026-03-30 Acquisition of Dexibit. The optionality is essentially free at current valuation.

Key risks

1. Customer concentration and virtual-queuing erosion — two customers each account for >10% of revenue ($27.9m + $22.8m combined in 2025). One major LoQueue customer chose not to renew at end of January 2026, and another extended only on "revised commercial terms" — guest-experience revenue fell 9.9% in 2025 and virtual queuing -5.8% 2026-03-30 Final Results.
2. Persistent earnings disappointment and 2026 down-year guidance — 2024 revenue guidance was revised down mid-year (Aug 2024 trading statement cut full-year from "not less than $160m" to $150-153m), 2025 narrowed to lower end of range mid-year, and 2026 guidance of $146m revenue is a decline of 6% on 2025 2025-09-09 Half-year, 2024-08-15 Trading Statement. The pattern is repeated guidance resets.
3. CEO transition risk amid macro and Middle East uncertainty — Long-tenured CEO Steve Brown stepping down May 2026 to incoming COO Lee Cowie 2026-03-30 Final Results. Middle East PS milestones expected to deliver $4.5-5.0m in 2026 are subject to customer acceptance and regional risk. Combined with the planned 45-role headcount cut in Jan 2026, execution risk is elevated.

Operating leverage

The cost base is heavily fixed — payroll dominates underlying admin expense ($99.5m in 2025, ~64% of revenue) and development spend ($45.7m, ~29.5% of revenue) is essentially fixed across modest revenue changes. At 78.5% gross margin (90% if Distribution is netted), an incremental dollar of transactional Ticketing or LoQueue revenue would drop ~85-90% to gross profit and ~70-80% to operating profit at current scale. If 2026 revenue beat guidance by 10-15% (i.e. ~$160-170m vs $146m guided), Cash EBITDA could plausibly expand from $20m to $30-35m, i.e. ~50-75% incremental profit from ~10-15% incremental revenue. However, the inverse has been operating — flat revenue + wage inflation has seen Cash EBITDA margin compress from 17% (2022) to 14.8% (2025) and 7.5% in H1 2025. The Group has stated a medium-term Cash EBITDA target of ≥20% but margins have been moving the wrong way. Inflection points: re-acceleration of LoQueue penetration, Adyen payments partnership (capital-light incremental revenue), Freedom hitting scale, and accesso Intelligence monetisation 2026-03-30 Final Results.

Value-trap signals

• Three consecutive years of essentially flat revenue ($149.5m → $152.3m → $155.1m), with 2026 guided down to $146m.
• Repeated guidance cuts within the year (Aug 2024, July 2025).
• High customer concentration (two customers >10%, both in the more volatile LoQueue segment).
• $11.3m drawn on RCF and ~$11.9m share repurchase in 2025 + £14.5m tender — capital return funded from cash + drawing on facility rather than from free cash growth.
• Cash EBITDA margin trending lower despite operational restructurings and 45-role cuts in January 2026.
• AI marketing language is heavy but Dexibit ARR was only ~$1.4m at acquisition.

Earnings vs expectations

Pattern: original ambitions are repeatedly trimmed during the year, then the revised lower targets are met or modestly beaten. Net effect over the cycle is a modest-miss-then-meet track record — not a beat story.

Conviction

3 — moderate.

• Supports: clean US-GAAP-style disclosure with strong revenue-by-product and geography breakdown; fortress balance sheet that removes downside risk; multiple valuation lenses converge near 300-380p.
• Limits: 2026 is a transition year (new CEO, Dexibit integration, virtual queuing reset) which makes near-term earnings power genuinely uncertain; the AI/Dexibit revenue trajectory is a call we cannot anchor with confidence; lack of clear catalyst to re-rate.